Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Catalyst Pharma (CPRX)
NASDAQ:CPRX
Catalyst Pharma (CPRX) Ownership - Who Owns Catalyst Pharma?
2,031 Followers
Catalyst Pharma (CPRX) Ownership Overview
13.77% Insiders
17.60% Mutual Funds
28.08% Other Institutional Investors
40.55% Public Companies and Individual Investors
The ownership structure of Catalyst Pharma (CPRX) stock is a mix of institutional, retail and individual investors. Approximately 45.68% of the company’s stock is owned by Institutional Investors, 13.77% is owned by Insiders and 40.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 11, 2024 | xxxxxxxxxxxxx | $121184 | |
| Jun 05, 2024 | Molly Harper Director | xxxxxxxxxxxxx | $86928 |
| Mar 28, 2024 | Brian Elsbernd Chief Compliance/legal Officer | xxxxxxxxxxxxx | $411000 |
| Dec 19, 2023 | Molly Harper Director | xxxxxxxxxxxxx | $201420 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $560896 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1673700 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1795146 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $8029902 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,412,659 | Institution | 11.36% | 227,210,443 | |
| 9,130,817 | Institution | 7.73% | 154,676,040 | |
| 6,775,662 | Institution | 5.74% | 114,779,714 | |
| 5,147,469 | Institution | 4.36% | 87,198,125 | |
| 4,528,256 | Insider | 3.83% | 76,708,657 | |
| 3,656,894 | Institution | 3.10% | 61,947,784 | |
| 2,893,308 | Institution | 2.45% | 49,012,638 | |
| 2,467,045 | Institution | 2.09% | 41,791,742 | |
| 2,084,013 | Institution | 1.76% | 35,303,180 | |
| 1,639,854 | Institution | 1.39% | 27,779,127 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,147,469 | Institution | 4.36% | 87,198,125 | |
| 1,639,854 | Institution | 1.39% | 27,779,127 | |
| 1,177,541 | Institution | 1.00% | 19,947,545 | |
| 1,128,058 | Institution | 0.96% | 19,109,303 | |
| 1,031,072 | Institution | 0.87% | 17,466,360 | |
| 890,500 | Institution | 0.75% | 15,085,070 | |
| 862,435 | Institution | 0.73% | 14,609,649 | |
| 742,200 | Institution | 0.63% | 12,572,868 | |
| 707,675 | Institution | 0.60% | 11,988,015 | |
| 672,701 | Institution | 0.57% | 11,395,555 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,326,794 | Institution | 6.20% | 124,115,890 | |
| 3,549,557 | Institution | 3.01% | 54,982,638 | |
| 3,084,252 | Institution | 2.61% | 52,247,229 | |
| 2,886,100 | Institution | 2.44% | 48,255,592 | |
| 2,306,383 | Institution | 1.95% | 39,070,128 | |
| 1,906,372 | Institution | 1.61% | 31,874,540 | |
| 1,724,664 | Institution | 1.46% | 26,715,045 | |
| 1,099,908 | Institution | 0.93% | 18,632,442 | |
| 1,042,405 | Institution | 0.88% | 17,658,341 | |
| 974,261 | Institution | 0.82% | 16,289,644 |
FAQ
Who Owns Catalyst Pharma (CPRX)?
According to the latest TipRanks data, approximately 28.08% of the company's stock is held by institutional investors, 13.77% is held by insiders, and 40.55% is held by retail investors.
What percentage of Catalyst Pharma (CPRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 28.08% of Catalyst Pharma (CPRX) stock is held by institutional investors.
What percentage of Catalyst Pharma (CPRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.55% of Catalyst Pharma (CPRX) stock is held by retail investors.
Who owns the most shares of Catalyst Pharma (CPRX)?
iShares owns the most shares of Catalyst Pharma (CPRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.